OtherArticle
Suppression and Regression of Choroidal Neovascularization by Systemic Administration of an α5β1 Integrin Antagonist
Naoyasu Umeda, Shu Kachi, Hideo Akiyama, Grit Zahn, Doerte Vossmeyer, Roland Stragies and Peter Campochiaro
Molecular Pharmacology March 9, 2006, DOI: https://doi.org/10.1124/mol.105.020941
Naoyasu Umeda
Shu Kachi
Hideo Akiyama
Grit Zahn
Doerte Vossmeyer
Roland Stragies
Jump to comment:
No eLetters have been published for this article.
In this issue
OtherArticle
Suppression and Regression of Choroidal Neovascularization by Systemic Administration of an α5β1 Integrin Antagonist
Naoyasu Umeda, Shu Kachi, Hideo Akiyama, Grit Zahn, Doerte Vossmeyer, Roland Stragies and Peter Campochiaro
Molecular Pharmacology March 9, 2006, DOI: https://doi.org/10.1124/mol.105.020941
OtherArticle
Suppression and Regression of Choroidal Neovascularization by Systemic Administration of an α5β1 Integrin Antagonist
Naoyasu Umeda, Shu Kachi, Hideo Akiyama, Grit Zahn, Doerte Vossmeyer, Roland Stragies and Peter Campochiaro
Molecular Pharmacology March 9, 2006, DOI: https://doi.org/10.1124/mol.105.020941
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement